Keyphrases
Ablating
16%
Active Sites
16%
Aspartic Acid
16%
Atypical Hemolytic Uremic Syndrome (aHUS)
16%
B Cells
16%
C1 Esterase Inhibitor
100%
Cell-to-cell
16%
Coagulation
16%
Diarrhea
16%
Escherichia Coli O157
100%
Extracellular Matrix Protein 1 (ECM1)
16%
Feces
16%
Glutamic Acid
16%
Hemorrhagic Colitis
16%
Human Disease
16%
Intestinal Edema
16%
Macrophage-like
16%
Metalloprotease
100%
PO157
33%
Protease
33%
Secreted Protease
16%
Secretion Systems
16%
Serine Protease Inhibitor
33%
T Cells
33%
Thrombotic
16%
Tissue Damage
16%
Type II Secretion
16%
Unknown Function
16%
Virulence Plasmid
16%
Medicine and Dentistry
Aspartic Acid
16%
Atypical Hemolytic Uremic Syndrome
16%
B Cell
16%
Cleft
100%
Complement Component C1s Inhibitor
100%
Diarrhea
16%
Diseases
16%
Edema
16%
Escherichia Coli O157
100%
Feces
16%
Glutamic Acid
16%
Hemorrhagic Colitis
16%
Infection
16%
Macrophage
16%
Metalloproteinase
100%
Proteinase
50%
Scleroprotein
16%
Secretory Pathway
16%
Serine Proteinase Inhibitor
33%
T Cell
33%
Tissue Injury
16%
Virulence Plasmid
16%
Pharmacology, Toxicology and Pharmaceutical Science
Aspartic Acid
16%
Complement Component C1s Inhibitor
100%
Diarrhea
16%
Diseases
16%
Edema
16%
Escherichia Coli O157
100%
Glutamic Acid
16%
Hemolytic Uremic Syndrome
16%
Hemorrhagic Colitis
16%
Infection
16%
Metalloproteinase
100%
Proteinase
50%
Scleroprotein
16%
Serine Proteinase Inhibitor
33%
Tissue Injury
16%
Virulence Plasmid
16%
Immunology and Microbiology
Aspartic Acid
16%
B Cell
16%
C1-Inhibitor
100%
Colitis
16%
Escherichia Coli O157:H7
100%
Extracellular Matrix
16%
Feces
16%
Glutamic Acid
16%
Infection
16%
Macrophage
16%
Matrix Protein
16%
Secretory Pathway
16%
Serine
33%
T Cell
33%
Virulence Plasmid
16%